Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAD51 associated protein 2 (RAD51AP2) is a vertebrate and meiotic-specific large protein (1159 amino acids) that interacts specifically with the recombinase RAD51 through a conserved C-terminal motif also shared with RAD51AP1[1][2]. RAD51AP2 is expressed predominantly in meiotic tissues such as the adult testis and fetal ovary, and is not found in mitotic somatic cells, even after DNA damage[1][2]. The biological function of RAD51AP2 appears to be specialized in supporting homologous recombination during meiosis, potentially mediating RAD51 function in meiotic synapsis or strand exchange, but it is not part of common therapeutic target classes such as receptors or enzymes[1][2][3]. RAD51AP2 is not a known direct target of therapeutic drugs, nor is it a well-established biomarker for disease or therapy, though associations with reproductive tract cancers have been reported[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAD51 associated protein 2 (RAD51AP2).